APA引文

National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, & ebrary, Inc. (2011). Risk-characterization framework for decision-making at the food and drug administration. National Academies Press.

Chicago Style (17th ed.) Citation

National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, and Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. Washington, DC: National Academies Press, 2011.

MLA引文

National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, and Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. National Academies Press, 2011.